Cardiology & Vascular Research

Open Access ISSN: 2639-8486

Abstract


Primary Osteolytic Tumor Revealing A Deep Vein Thrombosis Of The Right Lower Limb In One Case

Authors: Soumaoro Morlaye, Barry Ibrahima Sory, Samoura Aly, Balde Elhadj Yaya, Camara Abdoulaye, Koivogui Diara, Samoura Sana, Balde Alpha Abdoulaye, Koivogui Kokoulo, Toure Demba, Kourouma Moussa, Sow Aminata, Balde Mamadou Dadhi, Conde Mamadi.

Introduction: Venous thromboembolism is a unique entity which groups together two main clinical expressions: deep vein thrombosis (DVT) and pulmonary embolism (PE) Deep vein thrombosis of the lower limb is a multifactorial disorder characterized by the formation of a thrombus of fibrino cruori which can be partial or total [1]. Objective of this study was to make a detailed description of this disease association.

Observation: He is a 65-year-old farmer from the village of Coyah, height = 1.67cm, weight = 58 kg, Admitted to our department on January 02, 2020 for: Painful swelling of the lower right limb, palpitations, headache, vertigo, asthenia physical, anorexia all evolving for a month with a history of arterial hypertension for more than 5 years irregular treatment, no history of family tumor, no active or passive smoking, hypertensive under Coveram10 / 10mg (Ramipril / Amlodipine).

Discussion: The incidence of VTE in cancer remains difficult to know due to the heterogeneity of this population and the difficulty of conducting large epidemiological studies [7]. Our results are identical to those of the literature. Cancer is the third leading cause of VTE (20%) in the general population, after surgery (24%) and bed rest (22%) [8]. VTE affects 10 to 20% of cancer patients. It is the second leading cause of death in these patients.

Conclusion: The relationship between thrombosis and cancer, first described nearly 150 years ago by French physician Armand Trousseau, is still relevant today. The significant improvement in our knowledge in this field makes it possible to optimize anti-thrombotic prophylactic strategies which will therefore also be, to a certain extent, antineoplastic. Thus, the control of coagulation during cancer not only prevents vascular complications but it could also potentially reduce tumor progression, metastatic spread and even prolong the survival of these patients.

View/Download pdf